By Jeff Overley ( January 30, 2018, 7:50 PM EST) -- The U.S. Food and Drug Administration's latest disciplinary letters scolded a drugmaker for lying to customers about product testing, rebuked a drug company for using dilapidated equipment and chided a laser corporation for neglecting complaints about burns and scars. Here's a look at the FDA smackdowns....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.